Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Cancer, Muscle-invasive”

688 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 688 results

Not applicableStudy completedNCT02203136
What this trial is testing

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 16
Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00380029
What this trial is testing

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
UNC Lineberger Comprehensive Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT02343614
What this trial is testing

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non Muscle Invasive Bladder Cancer
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 58
Very early researchEnrolling By InvitationNCT06204614
What this trial is testing

Drug Screening Using IMD in Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Urothelial Carcinoma
Brigham and Women's Hospital 18
Large-scale testing (Phase 3)Looking for participantsNCT07097142
What this trial is testing

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
NRG Oncology 486
Testing effectiveness (Phase 2)Ended earlyNCT03719300
What this trial is testing

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Anchiano Therapeutics Israel Ltd. 32
Not applicableLooking for participantsNCT07202819
What this trial is testing

Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy

Who this might be right for
Muscle Invasive Bladder Cancer
Assiut University 76
Not applicableStudy completedNCT01004211
What this trial is testing

Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging

Who this might be right for
Non Muscle Invasive Bladder Cancer
Paolo Puppo 188
Large-scale testing (Phase 3)Study completedNCT00330707
What this trial is testing

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
National University Hospital, Singapore 140
Testing effectiveness (Phase 2)Study completedNCT04919512
What this trial is testing

TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 163
Not applicableUnknownNCT04664816
What this trial is testing

Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Mansoura University 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT06305767
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07474064
What this trial is testing

Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
chenxu 146
Testing effectiveness (Phase 2)Study completedNCT02690558
What this trial is testing

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

Who this might be right for
Bladder Cancer
UNC Lineberger Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)UnknownNCT04738630
What this trial is testing

Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Taizhou Hanzhong biomedical co. LTD 110
Not applicableStudy completedNCT02298998
What this trial is testing

Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

Who this might be right for
Bladder Cancer
The University of Texas Health Science Center at San Antonio 41
Not applicableLooking for participantsNCT07673016
What this trial is testing

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Who this might be right for
Bladder CancerUrothelial Carcinoma (UC)Hematuria+1 more
Convergent Genomics, Inc. 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT07647289
What this trial is testing

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)
Peking University Third Hospital 58
Large-scale testing (Phase 3)Active Not RecruitingNCT03091660
What this trial is testing

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Who this might be right for
Stage 0 Bladder Urothelial CarcinomaStage 0is Bladder Urothelial CarcinomaStage I Bladder Urothelial Carcinoma
SWOG Cancer Research Network 1,000
Next Page